Medullary thyroid carcinoma - Adverse events during systemic treatment: risk-benefit ratio
Arch. endocrinol. metab. (Online); 61 (4), 2017
ABSTRACT Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from parafollicular C cells of the thyroid and associated with mutations in the proto-oncogene REarranged during Transfection (RET). The prognosis of MTC depends on clinical stage, with a 95.6% 10-year survival rate amo...
Anilidas/efectos adversos, Anilidas/uso terapéutico, Carcinoma Neuroendocrino/tratamiento farmacológico, Carcinoma Neuroendocrino/metabolismo, Piperidinas/efectos adversos, Piperidinas/uso terapéutico, Inhibidores de Proteínas Quinasas/efectos adversos, Inhibidores de Proteínas Quinasas/uso terapéutico, Piridinas/efectos adversos, Piridinas/uso terapéutico, Quinazolinas/efectos adversos, Quinazolinas/uso terapéutico, Medición de Riesgo, Neoplasias de la Tiroides/tratamiento farmacológico, Neoplasias de la Tiroides/metabolismo